Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.
about
Propofol: a review of its role in pediatric anesthesia and sedationThe pharmacokinetics of methadone in adolescents undergoing posterior spinal fusion.Validation of an HPLC assay for determination of Telazol in pregnant pigs: application to placental transfer studyAn integrated population pharmacokinetic meta-analysis of propofol in morbidly obese and nonobese adults, adolescents, and children.Covariates of intravenous paracetamol pharmacokinetics in adultsPopulation pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents.Body mass index influences the response to infliximab in ankylosing spondylitisAnesthetic Pharmacology and the Morbidly Obese Patient.My child is unique; the pharmacokinetics are universal.Impact of obesity on drug metabolism and elimination in adults and children.Perioperative management of the severely obese patient: a selective pathophysiological review.Understanding dosing: children are small adults, neonates are immature children.Prediction of Fat-Free Mass in Children.Prediction of Intravenous Busulfan Clearance by Endogenous Plasma Biomarkers Using Global Pharmacometabolomics.Joint feedback analysis modeling of nonesterified fatty acids in obese Zucker rats and normal Sprague-Dawley rats after different routes of administration of nicotinic acid.High-performance liquid chromatographic determination of propofol in human plasma: comparison of different heteroscedastic calibration curve models.Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions.Sex difference in formation of propofol metabolites: a replication study.What is the best size predictor for dose in the obese child?Propofol Clearance in Morbidly Obese Children and Adolescents : Influence of Age and Body Size.Propofol clearance in morbidly obese children and adolescents: influence of age and body size.Predicting weight using postmenstrual age--neonates to adults.Morbid Obesity Alters Both Pharmacokinetics and Pharmacodynamics of Propofol: Dosing Recommendation for Anesthesia Induction.Optimal Drug Dosing in the Obese--Still Many Years Ahead.Pharmacokinetics and pharmacodynamics--is there anything new?Obesity and allometric scaling of pharmacokinetics.Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients.Getting the dose right for obese children.Feedback modeling of non-esterified fatty acids in obese Zucker rats after nicotinic acid infusions.Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects.
P2860
Q26796361-A5DB3A5A-2F96-4C96-9249-3D8C19DDA2FCQ30456107-6639E711-DBBB-4249-A5B0-905FEA5868C3Q33594046-CD9751BA-8787-4EE0-88C8-CDC8AD084FFAQ33633622-01A72189-4D3A-4482-BF59-9D41E0BDB7E3Q34193839-5E16AF22-48B4-4C20-AE9D-8296926E6123Q35893890-D4B307A0-EC2E-4BD7-A21C-267CF3E6C561Q36245977-DF2F730E-04B4-4479-9590-EB037B40F202Q36697500-B7A5BAF2-9E2A-4C75-BC6D-A827998FE7D7Q37973872-58C9905D-FA40-4B6E-BB42-61BB791D32C4Q37997025-3645F1B7-0D14-475B-B18D-2A64A5EC967DQ38029544-4A6EEE1D-4FC2-4F97-BA38-3A369DAB7043Q38119839-AE128BC0-59F8-4D64-BF98-70552C9EBAE1Q40976960-F34F912F-0536-4569-BFAF-48119C3A54A4Q41653330-A462FB65-54F6-4F66-A67A-8E6892B25F04Q42203740-98744B04-F25C-4741-9C86-3574DC1C81CEQ42213605-690BE856-0599-4204-B6B8-FFC84B628967Q42635454-F3EEE0D2-6B44-41A7-A8BF-6474CECD2675Q45001357-B9679B4F-01D0-4F2F-A539-FFF7644629BAQ47179401-D1D18BA1-4137-47F0-8A08-C618E57269E0Q47294518-8CDE704A-1E90-485E-812C-B6E21B362998Q47304379-EFF139BF-6FBA-4AE0-A2A5-D14D21E7E7CFQ47391137-39FE6BAD-3E86-4AB5-88DF-7EC6DB723280Q47402985-78B816F0-A009-4423-AA86-932D16E949C4Q47668991-E5C8AD85-B18D-4FF6-A9CA-F07A69CEA0FBQ48206441-5FB85E58-0D78-4EBD-B1C8-A7D2FBF1C0AAQ48224918-4A348B4E-7484-4D8F-BD08-1F25632F1C7CQ48224924-8D3E5681-4386-41A0-9400-6940ED265A1AQ48341261-D61BF2BB-2AA3-4B57-847F-7456AC901A8AQ54785515-B20F462F-1142-429A-A7EF-DFDE83156B16Q55476359-A5CAB328-5A00-4046-81B7-38DD1C189CF5
P2860
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.
@en
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.
@nl
type
label
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.
@en
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.
@nl
prefLabel
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.
@en
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.
@nl
P2093
P356
P1476
Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model
@en
P2093
B J Anderson
L I Cortínez
L Olivares
M M R F Struys
P Sepulveda
P304
P356
10.1093/BJA/AEQ195
P407
P50
P577
2010-08-14T00:00:00Z